Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 04, 2024

SELL
$114.26 - $136.0 $571,300 - $680,000
-5,000 Reduced 90.91%
500 $61.5 Million
Q3 2023

Oct 25, 2023

SELL
$122.0 - $145.31 $40,870 - $48,678
-335 Reduced 5.74%
5,500 $712 Million
Q2 2023

Jul 27, 2023

SELL
$122.5 - $147.16 $104,125 - $125,086
-850 Reduced 12.72%
5,835 $723 Million
Q1 2023

May 15, 2023

SELL
$133.98 - $160.47 $40,194 - $48,141
-300 Reduced 4.29%
6,685 $978 Million
Q4 2022

Feb 17, 2023

BUY
$129.72 - $159.85 $906,094 - $1.12 Million
6,985 New
6,985 $1.11 Billion

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Compass Wealth Management LLC Portfolio

Follow Compass Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Compass Wealth Management LLC with notifications on news.